Skip to content
Tuesday, October 27, 2026 · Today’s edition, 6:30 a.m. ETTue, Oct 27 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

GNOMvsIWM

Global X Genomics & Biotechnology ETF against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
GNOM 149IWM 111Oct 25Oct 26GROWTH OF $100
Head to head
GNOMIWM
Expense ratio0.50%0.19%
Assets$85M$74.2B
Net flow, 1 month—−$1.3B
Net flow, 1 year—−$4.1B
Return, YTD+46.2%+12.5%
Return, 1 year——
Avg daily volume39K25.1M
Holdings411941
ListedApr 5, 2019May 22, 2000
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.